Possible importance of immunoglobulin e in foetal loss by mothers with anti-SSA antibody

Scandinavian Journal of Rheumatology

Volumn 33, Issue 1, 2004, Pages 44-46

  Sekigawa, I ^a   Seta, N ^a   Yamada, M ^a   Iida, N ^a   Hashimoto, H ^b   Ogawa, H ^b  

^a JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BUCILLAMINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; MIZORIBINE; PREDNISOLONE; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS WASTAGE; HUMAN; IMMUNOASSAY; MIXED CONNECTIVE TISSUE DISEASE; PREGNANCY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; FETAL DEATH; HEART BLOCK; HUMANS; IMMUNOGLOBULIN E; MATERNAL AGE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PREVALENCE; PROBABILITY;

EID: 1542327584     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740310004658     Document Type: Article

References (14)

1. Hull RG, Harris EN, Morgan SH, Hughes GR. Anti-Ro antibodies and abortions in women with SLE. Lancet 1983; 2:1138.
2. Ramsey-Goldman R, Hom D, Deng JS, Ziegler GC, Kahl LE, Steen VD, et al. Anti-SSA antibodies and fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 1986;29:1269-73.
3. Watson RM, Braunstein BL, Watson AJ, Hochberg MC, Provost TT. Fetal wastage in women with anti-Ro (SSA) antibody. J Rheumatol 1986;13:90-4.
4. McHugh NJ, Reilly PA, McHugh LA. Pregnancy outcome and autoantibodies in connective tissue disease. J Rheumatol 1989;16:42-6.
5. Nossent HC, Swaak TJ. Systemic lupus erythematosus. IV. Analysis of the interrelationship with pregnancy. J Rheumatol 1990;17:771-6.
6. Hashimoto H, Takasaki Y, Hirokawa K. Systemic lupus erythematosus and congenital anomalies, focusing on neonatal lupus erythematosus and anti-SS-A/SS-B antibodies. Cong Anom 1992;32:301-7.
7. Buyon JP. Neonatal lupus: bedside to bench and back. Scand J Rheumatol 1996;25:271-6.
8. Mavragani CP, Dafni UG, Tzioufas AG, Moutsopoulos HM. Pregnancy outcome and anti-Ro/SSA in autoimmune disease: a retrospective cohort study. Br J Rheumatol 1998;37:740-5.
9. Mavragni CP, Ioannidis JP, Tzioufas AG, Hantoumi IE, Moutsopoulos HM. Recurrent pregnancy loss and autoantibody profile in autoimmune diseases. Rheumatology 1999;38: 1228-33.
10. Brucato A, Franceschini F, Doria A, Cimaz R, Meroni PL, Tincani A, et al. Pathogenetic associations of maternal anti-Ro/SSA antibodies. Lupus 2002;11:650.
11. Johnson PM, Chia KV, Risk JM, Barnes RM, Woodrow JC. Immunological and immunogenetic investigation of recurrent spontaneous abortion. Dis Markers 1988;6:163-71.
12. Asmussen K, Andersen V, Bendixen G, Bendtzen K, Prause JU, Thorn J, et al. Quantitative assessment of clinical disease status in primary Sjögren's syndrome. A cross-sectional study using a new classification model. Scand J Rheumatol 1997;26: 197-205.
13. Haga HJ, Jonsson R. The influence of age on disease manifestations and serological characteristics in primary Sjögren's syndrome. Scand J Rheumatol 1999;28:227-32.
14. Laurent J, Lagrue G, Sobel A. Increased serum IgE levels in patients with lupus nephritis. Am J Nephrol 1981;1:31-6.